|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.05 INR | -2.00% |
|
-0.50% | +66.99% |
| May. 21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| May. 20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.43B 66.38M 58.38M 54.24M 49.88M 93.55M 95.23M 649M 253M 3.14B 249M 244M 10.88B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.29B 75.29M 66.22M 61.52M 56.58M 106M 108M 736M 287M 3.56B 283M 277M 12.34B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.79% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -2.00% | ||
| 1 week | -0.50% | ||
| Current month | -3.42% | ||
| 1 month | -4.27% | ||
| 3 months | +38.26% | ||
| 6 months | +68.89% | ||
| Current year | +66.99% |
| 1 week | 120.05 | 125.5 | |
| 1 month | 111.5 | 133.95 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.00% | -0.50% | +2.91% | +0.04% | 67.98M | ||
| +0.57% | +0.13% | +16.45% | +78.10% | 48.31B | ||
| -0.50% | -0.41% | +67.13% | +107.90% | 35.33B | ||
| -1.56% | -3.13% | -4.88% | +32.80% | 11.85B | ||
| -1.11% | -3.73% | +16.41% | +81.64% | 11.64B | ||
| -0.84% | -0.19% | +36.48% | +136.73% | 8.99B | ||
| -0.27% | +0.42% | +51.66% | -6.22% | 6.93B | ||
| -0.77% | -3.00% | +13.55% | +32.01% | 6.72B | ||
| +0.24% | -4.02% | +2.19% | +192.78% | 6.43B | ||
| +1.60% | -9.55% | -30.77% | +8.47% | 5.66B | ||
| Average | -0.45% | -1.21% | +17.11% | +66.43% | 14.19B | |
| Weighted average by Cap. | -0.17% | -0.93% | +27.59% | +81.82% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.15M 34.43M 31.99M 29.42M 55.17M 56.16M 383M 149M 1.85B 147M 144M 6.42B | 3.74B 38.66M 34M 31.59M 29.05M 54.48M 55.46M 378M 147M 1.83B 145M 142M 6.34B |
| Net income | 122M 1.26M 1.1M 1.03M 944K 1.77M 1.8M 12.27M 4.79M 59.34M 4.72M 4.61M 206M | 58.38M 603K 530K 493K 453K 850K 865K 5.89M 2.3M 28.48M 2.26M 2.21M 98.79M |
| Net Debt | 1.16B 11.95M 10.51M 9.77M 8.98M 16.85M 17.15M 117M 45.55M 565M 44.88M 43.91M 1.96B | 863M 8.91M 7.84M 7.28M 6.7M 12.56M 12.78M 87.07M 33.96M 421M 33.46M 32.73M 1.46B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | ₹120.05 | -2.00% | 500 |
| 26-07-21 | ₹122.50 | -2.00% | 400 |
| 26-07-20 | ₹125.00 | -0.36% | 2,296 |
| 26-07-17 | ₹125.45 | +1.95% | 8,530 |
| 26-07-16 | ₹123.05 | +1.99% | 3,069 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















